These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6805158

  • 1. Mycobacterium tuberculosis tuberculin devoid of BCG common antigens.
    Stavri D, Stavri H, Claiciu I, Niculescu D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):399-401. PubMed ID: 6805158
    [No Abstract] [Full Text] [Related]

  • 2. Antigen study of Mycobacteria tuberculosis and BCG for detection of postvaccinal and infectious allergy.
    Mitinskaya LA.
    J Hyg Epidemiol Microbiol Immunol; 1975 Mar; 19(4):508-10. PubMed ID: 812912
    [No Abstract] [Full Text] [Related]

  • 3. Mycobacterial sensitivity elicited with a PPD devoided of the majority of the antigens common with BCG. Results on healthy-BCG vaccinated and tuberculous children.
    Stavri D, Claiciu I, Bărbulescu R, Stavri H, Niculescu D, Calciu B, Calciu M.
    Arch Roum Pathol Exp Microbiol; 1983 Mar; 42(2-3):221-6. PubMed ID: 6424630
    [No Abstract] [Full Text] [Related]

  • 4. The immunising efficiency of the avirulent strain M. tuberculosis Weiszfeiler no. 115/9.
    Sulová J, Spurná M.
    J Hyg Epidemiol Microbiol Immunol; 1975 Mar; 19(4):498-503. PubMed ID: 812910
    [No Abstract] [Full Text] [Related]

  • 5. [Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin].
    Kulagin PP, Martynova VA.
    Probl Tuberk; 1967 Mar; 45(9):74-7. PubMed ID: 4975371
    [No Abstract] [Full Text] [Related]

  • 6. [Immunological properties of attenuated tuberculosis strain "BK-Kharkov". I. The comparative characteristics of the structural lipids and their relationship to the immunogenic properties of the "BK-Kharkov" and BCG strains].
    Dikiĭ IL, Cherkas GP, Kandyba SG, Bykova VK.
    Mikrobiol Zh; 1976 Mar; 38(3):325-30. PubMed ID: 820948
    [No Abstract] [Full Text] [Related]

  • 7. Catalase electrophoretic mobility of some BCG substrains.
    Stavri D, Stavri H.
    J Hyg Epidemiol Microbiol Immunol; 1975 Mar; 19(4):462-6. PubMed ID: 812907
    [No Abstract] [Full Text] [Related]

  • 8. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions].
    Klose F, Schallehn G.
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180
    [No Abstract] [Full Text] [Related]

  • 9. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D, Stavri D, Stavri H, Claiciu I, Bărbulescu R.
    Arch Roum Pathol Exp Microbiol; 1983 Sep; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract] [Full Text] [Related]

  • 10. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U, Spratt JM, Britton WJ, Triccas JA.
    Vaccine; 2005 Feb 25; 23(14):1680-5. PubMed ID: 15705472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A.
    J Hyg Epidemiol Microbiol Immunol; 1975 Feb 25; 19(4):436-43. PubMed ID: 812905
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC.
    Vaccine; 2009 Jul 16; 27(33):4412-23. PubMed ID: 19500523
    [Abstract] [Full Text] [Related]

  • 15. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DN.
    Tuberculosis (Edinb); 2007 Mar 16; 87(2):155-65. PubMed ID: 17289434
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The specificity of a tuberculin devoid from cross-reacting antigens common with BCG, in eliciting the delayed hypersensitivity in men.
    Claiciu I, Stavri D, Bărbulescu R, Algeorge G, Calciu B, Calciu M, Stavri H, Niculescu D.
    Arch Roum Pathol Exp Microbiol; 1980 Mar 16; 39(4):369-76. PubMed ID: 6164354
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study of biological potencies of different tuberculins.
    Levy DT, Jablokova TB.
    Dev Biol Stand; 1986 Mar 16; 58 ( Pt B)():581-4. PubMed ID: 3111904
    [No Abstract] [Full Text] [Related]

  • 20. [Detection of urinary Mycobacterium antigens by latex agglutination test].
    Lazovskaia AL, Vorob'eva ZG, Sinitsina NA, Slinina KN.
    Probl Tuberk; 2001 Mar 16; (4):37-8. PubMed ID: 11523369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.